PanTher Therapeutics

Biotechnology, Medical, Therapeutics
Founded in 1/1/16
Cambridge, Massachusetts, United States
http://www.panthertx.com/
For Profit

About PanTher Therapeutics

PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 14 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 21319976 USD
  • Last Funding: 14200000 USD (Grant)
  • Funding Status: Early Stage Venture

Technology Stack

PanTher Therapeutics actively uses 14 products in their tech stack.

Market Presence

Industries: Biotechnology, Medical, Therapeutics

Headquarters: Cambridge, Massachusetts, United States

Leadership